Fluticasone Propionate + Formoterol Fumarate in pharma franchise in Sikkim

Fluticasone Propionate + Formoterol Fumarate in PCD pharma franchise in Shimla

Fluticasone Propionate + Formoterol Fumarate in top pharma company in Jodhpur

Fluticasone Propionate + Formoterol Fumarate in pcd pharma supplier in Madurai

Fluticasone Propionate + Formoterol Fumarate in phama franchise company in India
Fluticasone Propionate + Formoterol Fumarate in phama distributor in Raipur

Home/Products /fluticasone-propionate-500mcg-formoterol-fumarate-12mcg-life-cap

About the Product

Description


Flutialfa F 500 Capsules combine Fluticasone Propionate (500 mcg) and Formoterol Fumarate (12 mcg) in a unique formulation designed to manage and control chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). Fluticasone Propionate is a potent corticosteroid that reduces inflammation and prevents the exacerbation of symptoms. Formoterol Fumarate is a long-acting beta-agonist (LABA) that relaxes the muscles in the airways, promoting smooth breathing by improving airflow.

This dual-action therapy ensures long-lasting relief from bronchoconstriction, wheezing, and other respiratory discomforts. Flutialfa F 500 Capsules are ideal for patients requiring maintenance therapy for persistent asthma or COPD, helping to prevent flare-ups and improve the quality of life. Regular use helps achieve better symptom control and reduces the need for rescue medications.

Common side effects may include throat irritation, headache, nausea, cough, or dizziness. Rarely, it may cause increased heart rate, muscle cramps, or oral fungal infections. Rinse the mouth after use to reduce the risk of infections.

Flutialfa F 500 Capsules are indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

Not recommended for pregnant or breastfeeding women unless prescribed by a healthcare provider.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Fluticasone Propionate 500 mcg + Formoterol Fumarate 12 mcg in the PCD pharma franchise market?

This combination inhalation formulation is used for moderate to severe asthma and COPD management, making it a strong respiratory and critical-care segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this respiratory product in their range?

Medical distributors and wholesalers can benefit from consistent demand in pulmonology clinics, respiratory hospitals, and chronic airway disease management. It is commonly prescribed for patients requiring higher-strength inhaled corticosteroid and long-acting bronchodilator therapy.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Fluticasone Propionate + Formoterol Fumarate inhalation capsules with monopoly rights, quality respiratory manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this respiratory product?

Wholesalers and medical agencies benefit from steady chronic prescription demand, pulmonology clinic usage, and long-term therapy cycles in asthma and COPD management when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this inhalation capsule?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.